246 related articles for article (PubMed ID: 29616034)
1. Specific Inhibition of Complement Activation Significantly Ameliorates Autoimmune Blistering Disease in Mice.
Mihai S; Hirose M; Wang Y; Thurman JM; Holers VM; Morgan BP; Köhl J; Zillikens D; Ludwig RJ; Nimmerjahn F
Front Immunol; 2018; 9():535. PubMed ID: 29616034
[TBL] [Abstract][Full Text] [Related]
2. Autoantibody-induced intestinal inflammation and weight loss in experimental epidermolysis bullosa acquisita.
Ishii N; Recke A; Mihai S; Hirose M; Hashimoto T; Zillikens D; Ludwig RJ
J Pathol; 2011 Jun; 224(2):234-44. PubMed ID: 21381035
[TBL] [Abstract][Full Text] [Related]
3. The alternative pathway of complement activation is critical for blister induction in experimental epidermolysis bullosa acquisita.
Mihai S; Chiriac MT; Takahashi K; Thurman JM; Holers VM; Zillikens D; Botto M; Sitaru C
J Immunol; 2007 May; 178(10):6514-21. PubMed ID: 17475881
[TBL] [Abstract][Full Text] [Related]
4. Caspase-1-independent IL-1 release mediates blister formation in autoantibody-induced tissue injury through modulation of endothelial adhesion molecules.
Sadeghi H; Lockmann A; Hund AC; Samavedam UK; Pipi E; Vafia K; Hauenschild E; Kalies K; Pas HH; Jonkman MF; Iwata H; Recke A; Schön MP; Zillikens D; Schmidt E; Ludwig RJ
J Immunol; 2015 Apr; 194(8):3656-63. PubMed ID: 25795756
[TBL] [Abstract][Full Text] [Related]
5. Radiosensitive Hematopoietic Cells Determine the Extent of Skin Inflammation in Experimental Epidermolysis Bullosa Acquisita.
Iwata H; Witte M; Samavedam UK; Gupta Y; Shimizu A; Ishiko A; Schröder T; Seeger K; Dahlke M; Rades D; Zillikens D; Ludwig RJ
J Immunol; 2015 Sep; 195(5):1945-54. PubMed ID: 26202985
[TBL] [Abstract][Full Text] [Related]
6. Generation of antibodies of distinct subclasses and specificity is linked to H2s in an active mouse model of epidermolysis bullosa acquisita.
Ludwig RJ; Recke A; Bieber K; Müller S; Marques Ade C; Banczyk D; Hirose M; Kasperkiewicz M; Ishii N; Schmidt E; Westermann J; Zillikens D; Ibrahim SM
J Invest Dermatol; 2011 Jan; 131(1):167-76. PubMed ID: 20720563
[TBL] [Abstract][Full Text] [Related]
7. Complement-fixing anti-type VII collagen antibodies are induced in Th1-polarized lymph nodes of epidermolysis bullosa acquisita-susceptible mice.
Hammers CM; Bieber K; Kalies K; Banczyk D; Ellebrecht CT; Ibrahim SM; Zillikens D; Ludwig RJ; Westermann J
J Immunol; 2011 Nov; 187(10):5043-50. PubMed ID: 21967893
[TBL] [Abstract][Full Text] [Related]
8. Model systems duplicating epidermolysis bullosa acquisita: a methodological review.
Ludwig RJ
Autoimmunity; 2012 Feb; 45(1):102-10. PubMed ID: 21923614
[TBL] [Abstract][Full Text] [Related]
9. Binding of avian IgY to type VII collagen does not activate complement and leucocytes and fails to induce subepidermal blistering in mice.
Sesarman A; Mihai S; Chiriac MT; Olaru F; Sitaru AG; Thurman JM; Zillikens D; Sitaru C
Br J Dermatol; 2008 Mar; 158(3):463-71. PubMed ID: 18205879
[TBL] [Abstract][Full Text] [Related]
10. Granulocyte-dependent autoantibody-induced skin blistering.
Csorba K; Sitaru S; Sitaru C
J Vis Exp; 2012 Oct; (68):. PubMed ID: 23092942
[TBL] [Abstract][Full Text] [Related]
11. Induction of complement-fixing autoantibodies against type VII collagen results in subepidermal blistering in mice.
Sitaru C; Chiriac MT; Mihai S; Büning J; Gebert A; Ishiko A; Zillikens D
J Immunol; 2006 Sep; 177(5):3461-8. PubMed ID: 16920988
[TBL] [Abstract][Full Text] [Related]
12. Induction of dermal-epidermal separation in mice by passive transfer of antibodies specific to type VII collagen.
Sitaru C; Mihai S; Otto C; Chiriac MT; Hausser I; Dotterweich B; Saito H; Rose C; Ishiko A; Zillikens D
J Clin Invest; 2005 Apr; 115(4):870-8. PubMed ID: 15841176
[TBL] [Abstract][Full Text] [Related]
13. B cells, dendritic cells, and macrophages are required to induce an autoreactive CD4 helper T cell response in experimental epidermolysis bullosa acquisita.
Iwata H; Bieber K; Tiburzy B; Chrobok N; Kalies K; Shimizu A; Leineweber S; Ishiko A; Vorobyev A; Zillikens D; Köhl J; Westermann J; Seeger K; Manz R; Ludwig RJ
J Immunol; 2013 Sep; 191(6):2978-88. PubMed ID: 23960233
[TBL] [Abstract][Full Text] [Related]
14. Studies on complement deposits in epidermolysis bullosa acquisita and bullous pemphigoid.
Mooney E; Falk RJ; Gammon WR
Arch Dermatol; 1992 Jan; 128(1):58-60. PubMed ID: 1371212
[TBL] [Abstract][Full Text] [Related]
15. Recombinant human IgA1 and IgA2 autoantibodies to type VII collagen induce subepidermal blistering ex vivo.
Recke A; Trog LM; Pas HH; Vorobyev A; Abadpour A; Jonkman MF; van Zandbergen G; Kauderer C; Zillikens D; Vidarsson G; Ludwig RJ
J Immunol; 2014 Aug; 193(4):1600-8. PubMed ID: 25024393
[TBL] [Abstract][Full Text] [Related]
16. GM-CSF modulates autoantibody production and skin blistering in experimental epidermolysis bullosa acquisita.
Samavedam UK; Iwata H; Müller S; Schulze FS; Recke A; Schmidt E; Zillikens D; Ludwig RJ
J Immunol; 2014 Jan; 192(2):559-71. PubMed ID: 24337383
[TBL] [Abstract][Full Text] [Related]
17. Granulocyte-derived elastase and gelatinase B are required for dermal-epidermal separation induced by autoantibodies from patients with epidermolysis bullosa acquisita and bullous pemphigoid.
Shimanovich I; Mihai S; Oostingh GJ; Ilenchuk TT; Bröcker EB; Opdenakker G; Zillikens D; Sitaru C
J Pathol; 2004 Dec; 204(5):519-27. PubMed ID: 15538734
[TBL] [Abstract][Full Text] [Related]
18. Epidermolysis bullosa acquisita: what's new?
Ishii N; Hamada T; Dainichi T; Karashima T; Nakama T; Yasumoto S; Zillikens D; Hashimoto T
J Dermatol; 2010 Mar; 37(3):220-30. PubMed ID: 20507385
[TBL] [Abstract][Full Text] [Related]
19. Identification of quantitative trait loci in experimental epidermolysis bullosa acquisita.
Ludwig RJ; Müller S; Marques Ad; Recke A; Schmidt E; Zillikens D; Möller S; Ibrahim SM
J Invest Dermatol; 2012 May; 132(5):1409-15. PubMed ID: 22297639
[TBL] [Abstract][Full Text] [Related]
20. Clearance rates of circulating and tissue-bound autoantibodies to type VII collagen in experimental epidermolysis bullosa acquisita.
Kasperkiewicz M; Hirose M; Recke A; Schmidt E; Zillikens D; Ludwig RJ
Br J Dermatol; 2010 May; 162(5):1064-70. PubMed ID: 20222918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
